Literature DB >> 21365241

Refinement and reproducibility of histologic criteria for the assessment of microscopic lesions in patients with gastroesophageal reflux disease: the Esohisto Project.

Lisa Yerian1, Roberto Fiocca, Luca Mastracci, Robert Riddell, Michael Vieth, Prateek Sharma, Stefan Franzen, Paula Fernstrom, Magnus Ruth.   

Abstract

BACKGROUND: Standardized criteria for assessing microscopic esophageal lesions are required to test their utility as markers of gastroesophageal reflux disease (GERD). AIMS: To finalize draft criteria for assessing microscopic esophageal lesions associated with gastroesophageal reflux and to test them for interobserver agreement.
METHODS: An international group of gastrointestinal pathologists was convened to finalize, using a consensus-based approach, draft criteria for recognizing microscopic esophageal lesions. Finalized criteria were retested for interobserver variability by four of the pathologists using 120 digitized esophageal biopsy slides from patients with GERD.
RESULTS: The finalized criteria included further clarification on lesion definitions and new guidance on how to select the area for assessing each lesion. This latter refinement was guided by the high interobserver agreement observed when draft criteria were previously applied to biopsies where the assessment area was preselected. When finalized criteria were applied in the current study to digitized biopsies without a preselected assessment area, the pairwise agreement was 73-97% for basal cell hyperplasia, papillary elongation, intraepithelial eosinophil, neutrophil and mononuclear cell numbers, and active/healed erosions, with slightly lower agreement (64%) for dilated intercellular spaces (DIS). When a combined severity score was applied, the level of agreement was 77%. The mean kappa ranged from fair to high (0.26-0.77) for individual lesions and was high for the combined score (0.64).
CONCLUSIONS: These levels of agreement are comparable with or higher than those for other accepted histologic definitions. Further steps include clinical validation of these criteria by correlating microscopic lesions with clinical variables such as esophageal acid exposure.

Entities:  

Mesh:

Year:  2011        PMID: 21365241     DOI: 10.1007/s10620-011-1624-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  Interobserver variation in interpretation of serial liver biopsies from patients with chronic hepatitis C.

Authors:  K Grønbaek; P B Christensen; S Hamilton-Dutoit; B H Federspiel; E Hage; O J Jensen; M Vyberg
Journal:  J Viral Hepat       Date:  2002-11       Impact factor: 3.728

2.  Reassessment of the diagnostic value of histology in patients with GERD, using multiple biopsy sites and an appropriate control group.

Authors:  Patrizia Zentilin; Vincenzo Savarino; Luca Mastracci; Paola Spaggiari; Pietro Dulbecco; Paola Ceppa; Edoardo Savarino; Andrea Parodi; Carlo Mansi; Roberto Fiocca
Journal:  Am J Gastroenterol       Date:  2005-10       Impact factor: 10.864

3.  Histological consequences of gastroesophageal reflux in man.

Authors:  F Ismail-Beigi; P F Horton; C E Pope
Journal:  Gastroenterology       Date:  1970-02       Impact factor: 22.682

4.  Red streaks in the oesophagus in patients with reflux disease: is there a histomorphological correlate?

Authors:  M Vieth; J Haringsma; J Delarive; P H Wiesel; W Tam; J Dent; G N Tytgat; M Stolte; L Lundell
Journal:  Scand J Gastroenterol       Date:  2001-11       Impact factor: 2.423

5.  Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms.

Authors:  M Voutilainen; P Sipponen; J P Mecklin; M Juhola; M Färkkilä
Journal:  Digestion       Date:  2000       Impact factor: 3.216

6.  Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients.

Authors:  J Isolauri; M Luostarinen; E Isolauri; P Reinikainen; M Viljakka; O Keyriläinen
Journal:  Am J Gastroenterol       Date:  1997-01       Impact factor: 10.864

7.  Oesophageal histology in reflux oesophagitis.

Authors:  B J Collins; H Elliott; J M Sloan; R J McFarland; A H Love
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

8.  Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis.

Authors:  H S Winter; J L Madara; R J Stafford; R J Grand; J E Quinlan; H Goldman
Journal:  Gastroenterology       Date:  1982-10       Impact factor: 22.682

9.  Development of consensus guidelines for the histologic recognition of microscopic esophagitis in patients with gastroesophageal reflux disease: the Esohisto project.

Authors:  Roberto Fiocca; Luca Mastracci; Robert Riddell; Kaiyo Takubo; Michael Vieth; Lisa Yerian; Prateek Sharma; Paula Fernström; Magnus Ruth
Journal:  Hum Pathol       Date:  2009-10-01       Impact factor: 3.466

10.  Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial.

Authors:  L Lundell; S Attwood; C Ell; R Fiocca; J-P Galmiche; J Hatlebakk; T Lind; O Junghard
Journal:  Gut       Date:  2008-05-09       Impact factor: 23.059

View more
  18 in total

Review 1.  Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation.

Authors:  Arne Kandulski; Peter Malfertheiner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-22       Impact factor: 46.802

Review 2.  Changes in the esophageal mucosa of patients with non erosive reflux disease: How far have we gone?

Authors:  Christos Triantos; Nikolaos Koukias; Georgios Karamanolis; Konstantinos Thomopoulos
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

Review 3.  Expert consensus document: Advances in the physiological assessment and diagnosis of GERD.

Authors:  Edoardo Savarino; Albert J Bredenoord; Mark Fox; John E Pandolfino; Sabine Roman; C Prakash Gyawali
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-27       Impact factor: 46.802

4.  Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn.

Authors:  Edoardo Savarino; Patrizia Zentilin; Luca Mastracci; Pietro Dulbecco; Elisa Marabotto; Lorenzo Gemignani; Luca Bruzzone; Nicola de Bortoli; Anna Chiara Frigo; Roberto Fiocca; Vincenzo Savarino
Journal:  J Gastroenterol       Date:  2012-09-25       Impact factor: 7.527

Review 5.  Biomarkers of Reflux Disease.

Authors:  Leila Kia; John E Pandolfino; Peter J Kahrilas
Journal:  Clin Gastroenterol Hepatol       Date:  2015-09-25       Impact factor: 11.382

Review 6.  Patients with refractory reflux symptoms: What do they have and how should they be managed?

Authors:  P J Kahrilas; L Keefer; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2015-09       Impact factor: 3.598

7.  Multilayered epithelium at the gastroesophageal junction is a marker of gastroesophageal reflux disease: data from a prospective Central European multicenter study (histoGERD trial).

Authors:  Cord Langner; Eva-Maria Wolf; Wolfgang Plieschnegger; Michael Geppert; Bernd Wigginghaus; Gabriele M Höss; Andreas Eherer; Nora I Schneider; Peter Rehak; Michael Vieth
Journal:  Virchows Arch       Date:  2014-02-18       Impact factor: 4.064

Review 8.  Diagnostic Investigations of Gastroesophageal Reflux Disease: Who and When to Refer and for What Test?

Authors:  Arne Kandulski; Lukas Moleda; Martina Müller-Schilling
Journal:  Visc Med       Date:  2018-04-20

9.  Sclerosing Esophagitis with IgG4-positive Plasma Cell Infiltration.

Authors:  Shigeo Mori; Yoshiya Tahashi; Kazushige Uchida; Tsukasa Ikeura; Naoyuki Danbara; Takahiro Wakamatsu; Takeo Kusuda; Yu Takahashi; Masato Yanagawa; Mitsunobu Matsushita; Chisato Ohe; Taku Michiura; Kentaro Inoue; Masanori Kon; Kazuichi Okazaki
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

10.  Esophageal Baseline Impedance Reflects Mucosal Integrity and Predicts Symptomatic Outcome With Proton Pump Inhibitor Treatment.

Authors:  Chenxi Xie; Daniel Sifrim; Yuwen Li; Minhu Chen; Yinglian Xiao
Journal:  J Neurogastroenterol Motil       Date:  2018-01-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.